MOLECULAR PROFILING TO UNDERSTAND TREATMENT RESISTANCE AND RESPONSE IN GLIOBLASTOMA

Patients with glioblastoma experience a wide variation in response to standard treatment, with nearly 30% experiencing tumour progression during treatment, and nearly 7% surviving more than 5 years. CEST-MRI is sensitive to treatment-induced changes in tumour metabolism and can be used to evaluate t...

Descripción completa

Detalles Bibliográficos
Autores principales: Nikolopoulos, Marina, Wu, Megan, Bahcheli, Alexander, Kellett, Sorcha, Erickson, Anders, Myrehaug, Sten, Sahgal, Arjun, Spears, Melanie, Bayani, Jane, Das, Sunit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337568/
http://dx.doi.org/10.1093/noajnl/vdad071.040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337568/
http://dx.doi.org/10.1093/noajnl/vdad071.040

Ejemplares similares